Neuland Names Saharsh Davuluri CEO as $30M Hyderabad Peptide Plant Targets Mid-2026
Neuland appointed Saharsh Davuluri CEO to lead an aggressive peptide expansion, with a $30M Hyderabad facility and a 6.37 kL first module due by mid-2026.
Neuland appointed Saharsh Davuluri CEO to lead an aggressive peptide expansion, with a $30M Hyderabad facility and a 6.37 kL first module due by mid-2026.